-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Clinical trial using a drug form of IL-2 hopes to improve management of Type 1 diabetes
News and Views: Clinical Investigation
-
Clinical trial using a drug form of IL-2 hopes to improve management of Type 1 diabetes
News and Views: Clinical Investigation
-
Clinical trial using a drug form of IL-2 hopes to improve management of Type 1 diabetes
News and Views: Clinical Investigation
-
Clinical trial using a drug form of IL-2 hopes to improve management of Type 1 diabetes
News and Views: Clinical Investigation
-
Clinical trial using a drug form of IL-2 hopes to improve management of Type 1 diabetes
News and Views: Clinical Investigation
-
Clinical trial using a drug form of IL-2 hopes to improve management of Type 1 diabetes
News and Views: Clinical Investigation
-
Clinical trial using a drug form of IL-2 hopes to improve management of Type 1 diabetes
News and Views: Clinical Investigation
-
Clinical trial using a drug form of IL-2 hopes to improve management of Type 1 diabetes
News and Views: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 11
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 11
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 11
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 11
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 11
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 11
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 11
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 11
Acknowledgements: Clinical Investigation
-
Over reporting of p-values in the medical literature should be discouraged
Eric P Brass
Editorial: Clinical Investigation
-
Over reporting of p-values in the medical literature should be discouraged
Eric P Brass
Editorial: Clinical Investigation
-
Over reporting of p-values in the medical literature should be discouraged
Eric P Brass
Editorial: Clinical Investigation
-
Over reporting of p-values in the medical literature should be discouraged
Eric P Brass
Editorial: Clinical Investigation
-
Over reporting of p-values in the medical literature should be discouraged
Eric P Brass
Editorial: Clinical Investigation
-
Over reporting of p-values in the medical literature should be discouraged
Eric P Brass
Editorial: Clinical Investigation
-
Over reporting of p-values in the medical literature should be discouraged
Eric P Brass
Editorial: Clinical Investigation
-
Over reporting of p-values in the medical literature should be discouraged
Eric P Brass
Editorial: Clinical Investigation
-
New considerations in the design of clinical trials for amyotrophic lateral sclerosis
James D Berry, Merit E Cudkowicz
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for amyotrophic lateral sclerosis
James D Berry, Merit E Cudkowicz
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for amyotrophic lateral sclerosis
James D Berry, Merit E Cudkowicz
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for amyotrophic lateral sclerosis
James D Berry, Merit E Cudkowicz
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for amyotrophic lateral sclerosis
James D Berry, Merit E Cudkowicz
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for amyotrophic lateral sclerosis
James D Berry, Merit E Cudkowicz
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for amyotrophic lateral sclerosis
James D Berry, Merit E Cudkowicz
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for amyotrophic lateral sclerosis
James D Berry, Merit E Cudkowicz
Review Article: Clinical Investigation
-
Combination therapy for COPD: emerging evidence from recent clinical trials
Matthew C Miles, James F Donohue, Jill A Ohar
Review Article: Clinical Investigation
-
Combination therapy for COPD: emerging evidence from recent clinical trials
Matthew C Miles, James F Donohue, Jill A Ohar
Review Article: Clinical Investigation
-
Combination therapy for COPD: emerging evidence from recent clinical trials
Matthew C Miles, James F Donohue, Jill A Ohar
Review Article: Clinical Investigation
-
Combination therapy for COPD: emerging evidence from recent clinical trials
Matthew C Miles, James F Donohue, Jill A Ohar
Review Article: Clinical Investigation
-
Combination therapy for COPD: emerging evidence from recent clinical trials
Matthew C Miles, James F Donohue, Jill A Ohar
Review Article: Clinical Investigation
-
Combination therapy for COPD: emerging evidence from recent clinical trials
Matthew C Miles, James F Donohue, Jill A Ohar
Review Article: Clinical Investigation
-
Combination therapy for COPD: emerging evidence from recent clinical trials
Matthew C Miles, James F Donohue, Jill A Ohar
Review Article: Clinical Investigation
-
Combination therapy for COPD: emerging evidence from recent clinical trials
Matthew C Miles, James F Donohue, Jill A Ohar
Review Article: Clinical Investigation
-
Fingolimod for the treatment of multiple sclerosis: a review of the evidence from the FREEDOMS and TRANSFORMS studies
Bhupendra O Khatri, John F Kramer
Review Article: Clinical Investigation
-
Fingolimod for the treatment of multiple sclerosis: a review of the evidence from the FREEDOMS and TRANSFORMS studies
Bhupendra O Khatri, John F Kramer
Review Article: Clinical Investigation
-
Fingolimod for the treatment of multiple sclerosis: a review of the evidence from the FREEDOMS and TRANSFORMS studies
Bhupendra O Khatri, John F Kramer
Review Article: Clinical Investigation
-
Fingolimod for the treatment of multiple sclerosis: a review of the evidence from the FREEDOMS and TRANSFORMS studies
Bhupendra O Khatri, John F Kramer
Review Article: Clinical Investigation
-
Fingolimod for the treatment of multiple sclerosis: a review of the evidence from the FREEDOMS and TRANSFORMS studies
Bhupendra O Khatri, John F Kramer
Review Article: Clinical Investigation
-
Fingolimod for the treatment of multiple sclerosis: a review of the evidence from the FREEDOMS and TRANSFORMS studies
Bhupendra O Khatri, John F Kramer
Review Article: Clinical Investigation
-
Fingolimod for the treatment of multiple sclerosis: a review of the evidence from the FREEDOMS and TRANSFORMS studies
Bhupendra O Khatri, John F Kramer
Review Article: Clinical Investigation
-
Fingolimod for the treatment of multiple sclerosis: a review of the evidence from the FREEDOMS and TRANSFORMS studies
Bhupendra O Khatri, John F Kramer
Review Article: Clinical Investigation
-
New therapeutics for pulmonary arterial hypertension: do gene therapies have translational values?
Roxane Paulin, Marjorie Barrier, Sebastien Bonnet
Editorial: Clinical Investigation
-
New therapeutics for pulmonary arterial hypertension: do gene therapies have translational values?
Roxane Paulin, Marjorie Barrier, Sebastien Bonnet
Editorial: Clinical Investigation
-
New therapeutics for pulmonary arterial hypertension: do gene therapies have translational values?
Roxane Paulin, Marjorie Barrier, Sebastien Bonnet
Editorial: Clinical Investigation
-
New therapeutics for pulmonary arterial hypertension: do gene therapies have translational values?
Roxane Paulin, Marjorie Barrier, Sebastien Bonnet
Editorial: Clinical Investigation
-
New therapeutics for pulmonary arterial hypertension: do gene therapies have translational values?
Roxane Paulin, Marjorie Barrier, Sebastien Bonnet
Editorial: Clinical Investigation
-
New therapeutics for pulmonary arterial hypertension: do gene therapies have translational values?
Roxane Paulin, Marjorie Barrier, Sebastien Bonnet
Editorial: Clinical Investigation
-
New therapeutics for pulmonary arterial hypertension: do gene therapies have translational values?
Roxane Paulin, Marjorie Barrier, Sebastien Bonnet
Editorial: Clinical Investigation
-
New therapeutics for pulmonary arterial hypertension: do gene therapies have translational values?
Roxane Paulin, Marjorie Barrier, Sebastien Bonnet
Editorial: Clinical Investigation